scispace - formally typeset
S

Songhee Jeon

Researcher at Chonnam National University

Publications -  61
Citations -  1183

Songhee Jeon is an academic researcher from Chonnam National University. The author has contributed to research in topics: Neuroprotection & Parkinson's disease. The author has an hindex of 17, co-authored 58 publications receiving 973 citations. Previous affiliations of Songhee Jeon include Dongguk University.

Papers
More filters
Journal ArticleDOI

Electromagnetic fields induce neural differentiation of human bone marrow derived mesenchymal stem cells via ROS mediated EGFR activation

TL;DR: EMF induce neural differentiation through activation of EGFR signaling and mild generation of ROS in BM-MSCs by examining the signaling pathways involved in the neural differentiation by EMF.
Journal ArticleDOI

Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model

TL;DR: Results suggest that acupoint GB34‐specific EA changes protein expression profiles in the SN in favor of DA neuronal survival in MPTP‐treated mice, and that EA treatment may be an effective therapy for PD patients.
Journal ArticleDOI

From Peripheral to Central: The Role of ERK Signaling Pathway in Acupuncture Analgesia

TL;DR: The novel evidence of the local molecular signaling in acupuncture analgesia is presented by demonstrating that ERK activation in the skin layer contributes to the analgesic effect of acupuncture in a mouse pain model, which improves the understanding of the scientific basis underlyingupuncture analgesia.
Journal ArticleDOI

Acupuncture accelerates wound healing in burn-injured mice

TL;DR: It is demonstrated that acupuncture accelerates the skin regeneration process following deep second degree burns.
Journal ArticleDOI

Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer's disease model.

TL;DR: JNK activity was increased in A β42-expressing brains, and the Aβ42-induced defects were rescued by reducing JNK or caspase activity through genetic modification or pharmacological treatment, suggesting that the JNK/dFOXO pathway confers a therapeutic potential for AD.